Evidence map›Paper›PMID 41890070›Full record

ArticlebioRxiv : the preprint server for biology2026

Dirty mice better recapitulate key features of mRNA vaccine immunogenicity observed in humans.

Beatriz Praena, Frances K Shepherd, Cera A McDonald, Devyani Joshi, Sneh Lata Gupta, Madison L Ellis, Lilin Lai, Alberto Moreno, Shanley N Roach, Mark J Pierson and 5 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Beatriz PraenaDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis MN, USA.
Frances K ShepherdDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis MN, USA.
Cera A McDonaldDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis MN, USA.
Devyani JoshiCenter for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Sneh Lata GuptaCenter for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Madison L EllisCenter for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Lilin LaiCenter for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Alberto MorenoEmory Vaccine Center, Emory University, Atlanta, GA, USA.ORCID 0000-0002-3031-7194
Shanley N RoachDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis MN, USA.
Mark J PiersonDepartment of Lab Medicine and Pathology, University of Minnesota, Minneapolis MN, USA.
Adam J GilbertsenDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis MN, USA.
Carl DavisEmory Vaccine Center, Emory University, Atlanta, GA, USA.
Mehul S SutharCenter for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Jens WrammertCenter for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Ryan A LangloisDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis MN, USA.

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00017 · NIAID · EMORY UNIVERSITY · PI LOWEN, ANICE · 2021 to 2025
$27.3M
TRAINING-PULMONARY CELL &MOLECULAR BIOLOGY &PHYSIOLOGYT32HL007741 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI DUDLEY, R. ADAMS, INGBAR, DAVID H · 1994 to 2023
$13.9M
Natural model for evaluating within- and cross-species virus transmissionR01AI173043 · NIAID · UNIVERSITY OF MINNESOTA · PI Ryan Langlois, Zhongde Wang · 2023 to 2026
$2.9M
New mouse model to better predict human immunity to influenza vaccination and infectionR01AI150600 · NIAID · UNIVERSITY OF MINNESOTA · PI LANGLOIS, RYAN, MASOPUST, DAVID · 2021 to 2024
$2.5M
NHLBI NIH HHS T32 HL007741NIAID NIH HHS R01 AI150600NIAID NIH HHS R01 AI173043NIH HHS 75N93021C00017NIH HHS P51 OD011132
6 · The paper itself

Abstract

Although specific pathogen free (SPF) mice have traditionally been used to test candidate vaccines, recent work has demonstrated that "dirty" mice with broad microbial exposure more appropriately recapitulate human immune responses. Using a model where lab mice are co-housed with pet store mice, we modeled SARS-CoV-2 mRNA vaccine responses in dirty and traditional SPF models. We found that dirty mice show reduced serum spike-binding antibody titers after prime and require a second booster dose to reach SPF-level spike antibody titers. Additionally, spike antibodies showed faster waning in dirty mice through 5 months post-vaccination, and neutralizing activity of these antibodies were reduced against Omicron variants, directly comparable with observations in humans. We further investigated the seasonality and consistency of pathogens in cohoused mice, and the impact of serial microbial exposure on our animal model system. We found that pathogen exposure and T cell activation remained consistent over time, and that a single co-housing event was sufficient to provide broad microbial exposure. This work demonstrates that the dirty mouse co-housing system is a promising, translationally representative approach to screen candidate mRNA vaccines for efficacy and durability prior to human clinical trials.

Identifiers

PMID41890070
PMCPMC13014157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.